Stock 1877 SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Shanghai Junshi Biosciences Co., Ltd.

Equities

1877

CNE100003FF7

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:22 2024-04-29 am EDT 		5-day change 1st Jan Change
10.84 HKD +0.93% Intraday chart for Shanghai Junshi Biosciences Co., Ltd. +16.68% -44.24%
Apr. 25 Shanghai Junshi Biosciences Receives Hong Kong Approval for Cancer Drug Toripalimab MT
Apr. 24 Shanghai Junshi Biosciences Co., Ltd. Receives Notice from the Drug Office, Department of Health, the Government of the Hong Kong Special Administration Region CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shanghai Junshi Biosciences Co., Ltd. Announces Executive Changes
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Change of Chief Executive Officer
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Change of General Manager
CI
Shanghai Junshi Biosciences Co., Ltd. and Topalliance Biosciences Inc Appoints Li Ning as Vice Chairman of the Third Session of the Board
CI
Shanghai Junshi Biosciences Co., Ltd. Directors Appointments
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Resignation of Feng Hui as Chief Operations Officer and Announces Re-Designation of Feng Hui as Non-Executive Director from His Previous Role as an Executive Director
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Resignation of Wu Hai as Non-Executive Director
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Board Changes
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Board Changes
CI
Shanghai Junshi Biosciences Co., Ltd. Appoints Zou Jianjun as Executive Director
CI
Shanghai Junshi Biosciences Co., Ltd. Appoints Zou Jianjun as Deputy General Manager and Global Research and Development President of the Company with Effect from 20 April 2022
CI
Shanghai Junshi Biosciences Announces Appointment of Independent Non-Executive Director and Change in Composition of the Nomination Committee And the Remuneration and Appraisal Committee
CI
Junshi Biosciences Names Director as Co-CEO
MT
Shanghai Junshi Biosciences Co., Ltd. Announces Executive Changes
CI
Alphamab Oncology Hires Former Junshi Bio Marketing Head as Commercial Chief; Shares Jump 3%
MT
Shanghai Junshi Biosciences Co., Ltd. Announces Resignation of Jiang Hualiang as an Independent Non-Executive Director, Chairman of the Nomination Committee and Member of the Remuneration and Appraisal Committee
CI
Junshi Biosciences Appoints Wei Qian as Chief Commercial Officer
CI
Shanghai Junshi Biosciences Co., Ltd Announces Executive Changes
CI
Shanghai Junshi Biosciences Co., Ltd. Announces Management Changes
CI
Shanghai Junshi Biosciences Co., Ltd. Appoints Yuan Lu as Assistant to the General Manager and Chief of the Internal Audit Department
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1877 Stock
  4. News Shanghai Junshi Biosciences Co., Ltd.
  5. Insiders